bioMerieux SA Forecast, price target & analysts
bioMerieux SA Target price 2026 - Analyst rating & recommendation
bioMerieux SA Classifications & Recommendation
bioMerieux SA Price Target
| Target Price | €81.60 |
| Price | €77.70 |
| Potential |
5.02%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target bioMerieux SA 2027 .
The average bioMerieux SA target price is €81.60.
This is
5.02%
register free of charge
€105.00
35.14%
register free of charge
€66.66
14.21%
register free of charge
|
|
| A rating was issued by 19 analysts: 8 Analysts recommend bioMerieux SA to buy, 10 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the bioMerieux SA stock has an average upside potential 2027 of
5.02%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion € | 4.07 | 4.17 |
| 2.26% | 2.36% | |
| EBITDA Margin | 16.83% | 23.91% |
| 3.53% | 42.04% | |
| Net Margin | 9.77% | 12.40% |
| 10.06% | 26.96% |
17 Analysts have issued a sales forecast bioMerieux SA 2026 . The average bioMerieux SA sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an bioMerieux SA EBITDA forecast 2026. The average bioMerieux SA EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 bioMerieux SA Analysts have issued a net profit forecast 2026. The average bioMerieux SA net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 3.34 | 4.39 |
| 8.24% | 31.44% | |
| P/E | 17.70 | |
| EV/Sales | 2.13 |
17 Analysts have issued a bioMerieux SA forecast for earnings per share. The average bioMerieux SA EPS is
This results in the following potential growth metrics and future valuations:
Current bioMerieux SA Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BNP PARIBAS |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| PIPER SANDLER COMPANIES |
Locked
➜
Locked
|
Locked | Jul 29 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 10 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BNP PARIBAS:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
PIPER SANDLER COMPANIES:
Locked
➜
Locked
|
Jul 29 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 10 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jul 08 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
